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1. Introduction  
Epilepsy is a heterogeneous entity with enormous variation in etiology and clinical features 
and is defined as two unprovoked seizures of any type (Waaler et al., 2000). Epilepsy is one 
of the most common neurological disorders in pediatric and adult population (Moshé et al., 
2011).  Research in the past 20 years showed that the patients with epilepsy commonly have 
coexisting psychiatric conditions including mood disorders, anxiety disorders, psychotic 
disorders and attention deficit hyperactivity disorder (Garcia Morales et al., 2008; Waaler  et 
al., 2000; Ekinci et al., 2009). Historically, psychiatric disorders in epilepsy have been 
considered a consequence of psychosocial disturbance due to poor adaptation to a chronic 
disease with stigma (Thome Souza et al., 2004). However, recent studies indicates that there 
is a  bidirectional relationship between epilepsy and psychiatric disorders. This relationship 
may be conceptualized as an epiphenomena rather than cause–consequence factors (Kanner, 
2011; Thome Souza et al 2004).  
2. Anxiety disorders in epilepsy 
Among the psychiatric comorbidites in epilepsy, anxiety disorders are highly frequent and 
have a profound influence on the quality of life of epilepsy patients (Kanner et al., 2010; 
Beyenburg et al., 2005; Choi-Kwon et al., 2003; Johnson et al., 2004; Tellez-Zenteno et al., 
2007). Several studies have reported elevated rates of panic attacks, panic disorder, 
obsessive compulsive disorder (OCD), social anxiety disorder and generalized anxiety 
disorder (GAD) in adult patients with epilepsy as compared with the general population 
(Piazzini et al., 2001; Issacs, 2004; Baker at al., 2005; Marsh & Rao 2002; Vazquez & Devinsky 
2003).   
2.1 DSM-IV anxiety disorders 
The DSM-IV defines 11 different types of anxiety disorders. Generalized anxiety disorder 
presents with (GAD) a disabling and persistent worry that is free-floating and present much 
of the time for at least 6 months.  Somatic  or vegetative symptoms such as increased fatigue, 
insomnia, difficulty with concentration, and sleep problems are commonly seen  in GAD. 
Panic attacks are defined by sudden and severe paroxysmal episodes of anxiety of typically 
sudden onset and short duration. A frequency of more than one attack per week for a period 
of at least 1 month is in the diagnostic criteria of panic disorder. Obsessive–compulsive 
disorder (OCD) is characterized by recurrent unwanted, intrusive and stressing thoughts or 
images often allied with compulsive actions (American Psychiatric Association, 1994). 
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2.2 The prevalence and the phenomenology of anxiety disorders in epilepsy 
The differences in the methodology of the studies have affected the consistency of 
prevalence rates of anxiety disorders in epilepsy (Williams et al., 2002; Ekinci et al., 2009). 
The avaliable data indicates a prevalence somewhere between 14% and 78% (Wittchen et al., 
2002; Vasquez & Devinsky, 2003; Kanner et al., 2001) in adults and somewhere between 16% 
and 48% in children and adolescents (Ettinger et al., 1998; Williams et al., 2003; Caplan et al., 
2004; Alwash et al., 2000).  
It is important to note that  the special features of anxiety disorders in epilepsy have not 
been studied sufficiently in clinical and community studies. Therefore, it’s largely unknown 
if the current diagnostic instruments for anxiety disorders perform adequately in this special 
population. Because of the complex nature of epilepsy, the phenomenology of anxiety 
disorders may be different than in the general population, which can make it difficult to 
isolate symptoms to a single DSM-IV-TR diagnosis. For example, the fear of unexpected 
seizures in special places may lead to a variant of agoraphobia.  In children, the fear of 
having a seizure can be associated with anxiety about separation from the parents or home. 
The fear of embarrassment about having a seizure in public may also lead to a variant of 
social phobia and result in isolation of the patient from social activites (Ekinci et al., 2009; 
Beyenburg et al., 2005). It is also important to highlight that DSM-IV-TR criteria require the 
absence of a physiological condition when considering symptoms in anxiety disorders (DSM 
IV, 1994). However, experimental studies suggest that kindling mechanisms and the 
recurrent epileptic stimulation of the amygdala may predispose patients with epilepsy to 
interictal anxiety (Depaulis et al., 1997). Because of this, it would be reasonable to consider 
an alternative classification system for epilepsy-related anxiety that accounts for the 
different manifestations of anxiety in individuals with epilepsy. For instance, some 
individuals experience anxiety in response to the stress of the condition (i.e., reactive) or 
whereas others because of a preexisting propensity for anxiety (i.e., endogenous) (Ekinci et 
al 2009). Beyenburg et al. in his comprehensive review offer phenomenologic suggestions 
about the types of anxiety disorders in epilepsy (Beyenburg et al., 2005).  
3. Associated factors of anxiety disorders in epilepsy 
Multiple factors have been found to be associated with anxiety symptoms and/or DSM IV 
anxiety disorders in patients with epilepsy. In this chapter, the factors associated with 
anxiety disorders in epilepsy are grouped in five categories including: Neurobiological 
factors, psycholocial factors, epilepsy related factors, age of the patients and the medication 
related factors.  
3.1 Neurobiological factors  
There is neurobiological evidence for the  possible common pathophysiological mechanisms 
of anxiety symptoms and epileptic seizures. This theory is mainly based on the observation 
that epileptic activity in certain areas of the brain directly causes paroxysmal anxiety, 
usually in the form of panic (Chapouthier & Venault, 2001; Trimble & Van Elst, 2003). The 
amygdala seems to be a particularly important structure for the production of anxiety 
symptoms and epileptic discharges in temporal lobe epilepsy (Beyenburg et al., 2005). In 
correlation with this hypothesis,  patients with temporal lobe epilepsy and ictal anxiety 
symptoms have been found to have a reduced amygdala volume (Cendes et al., 1994). 
Neurotransmitter  systems are also suggested be related with the link of anxiety disorders 
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and epilepsy. The role of GABA receptors and neurotransmitters including serotonin, 
dopamine and noradrenaline in both epilepsy and anxiety disorders indicate another 
pathophysiological similarity between the two disorders (Beyenburg et al., 2005; Lydiard, 
2003;  Charney, 2003). 
3.2 Psychological factors 
Psychological factors, such as the unpredictability of seizures, the fear of death, feeling of 
poor control over seizures, and perceived stigma likely predispose some epilepsy patients to 
anxiety (Pellock, 2004; Jacoby et al., 2005; Beyenburg et al., 2005). Misinformation or 
insufficient information about the disorder also seems to be related to increased anxiety 
(Ekinci et al., 2009; Couldridge et al., 2001). Lower levels of epilepsy knowledge were found 
to be significantly related to higher levels of social anxiety, higher levels of depression, and 
lower levels of self-esteem (Baker et al., 2005).  
3.3 Epilepsy related factors 
Previous studies linked some epilepsy related factors with anxiety symptoms. Higher 
seizure frequency has been found to be associated with anxiety disorders in some adult 
studies (Jacoby et al., 1996). In the case of children and adolescents, most of the literature 
supports a direct relationship between increased seizure frequency and anxiety disorders 
(Williams et al., 2003; Ettinger et al., 1998; Kessler et al 2001; Oguz et al 2002; Alwash et 
al., 2000; Adeewuya et al., 2005). In adults, the risk of anxiety disorders appears to be 
higher in focal (especially temporal lobe) than in generalized epilepsies (Garcia Morales et 
al., 2008; Goldstein & Harden, 2000; Vasquez & Devinsky 2003; Marsh & Rao, 2002, 
Piazzini et al., 2001). Anxiety disorders were found to be linked with the seizures 
originated from left temporal lobe but this is not entirely consistent in the literature 
(Andelman et al., 2001). In  children and adolescents, the contribution of seizure type to 
anxiety disorders appears to be much less clear. Most of the studies have failed to 
demonstrate a relationship between seizure type and risk of anxiety [Williams et al., 2003; 
Ettinger et al., 1998; Oguz et al., 2002; Pianta & Lothman, 1994). Epilepsy surgery is also 
reported to be related with the development of anxiety symptoms. Transient anxiety 
symptoms have been reported after following temporal lobe surgery for epilepsy (Ring  
et al., 1998). 
3.4 Age as a factor 
The age of the patient and the age of seizure onset were examined as associated factors for 
anxiety disorders in epilepsy. In adult patients, first-onset epilepsy in late life is shown to be 
linked with higher levels of anxiety (Baker et al., 2001). However, in children and 
adolescents, most of the studies do not support a relationship between age at seizure onset 
and increased risk of anxiety (Williams et al., 2003; Ettinger et al., 1998; Pianta et al., 1994; 
Oguz et al., 2002). In pediatric population, older age has been found to be a significant risk 
factor for anxiety. Adolescents with epilepsy are considered to be at higher risk for anxiety 
than younger children (Oguz et al., 2002; Williams et al., 2003). There are several possible 
explanations for this relation. Adolescents have a greater cognitive capacity than children 
to understand and question the unpredictable and poorly controlled nature of the seizure 
disorder. This can, in turn, potentiate anxiety and contribute to negative emotional 
responses. Morever, with the significant social demands and challenges, adolescence is 
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unique among the other phases of development. Peer relationships are central to the 
teenage experience and the risk of having a seizure at school or in a social activity with 
friends is a severe threat to an adolescent’s ability to successfully achieve the 
developmental milestones for this age. This can result in significant problems with self-
esteem and potential social isolation, thus increasing the likelihood of anxiety in various 
forms (Ekinci et al., 2009).  
3.5 The possible role of antiepileptic drugs 
Most of the previous studies have demonstrated that  antiepileptic drug (AED) polytherapy 
is associated with increased risk of anxiety disorders (Mula & Sanders 2007; Williams et al., 
2003; Ettinger et al., 1998; Oguz et al., 2002; Adeewuya et al., 2005). This increased risk can 
occur as a side effect of the AEDs or as a function of complications related to AED 
withdrawal. However, it is unclear whether there is a direct causal relationship between  
AED polytherapy and anxiety.  It is also possible that the need of using AED polytherapy 
may reflect the the intractability of the seizure disorder. 
4. Treatment of anxiety disorders in epilepsy 
4.1 Psychosocial interventions  
For the optimal management of anxiety disorders in epilepsy, an essential component is 
the adequate explanation of the condition (Couldrigde et al., 2001; Kendal et al.,  
2004). The degree of information requested may vary relatively between patients and 
families in different socioculturel levels. A comprehensive psychoeducation can be best 
achieved  with the availability of professional specialists including nurses (Beyenburg  
et al., 2005). 
Regular psychiatric and/or psychological consultation that involves developmentally 
appropriate methods of approach is important. Among the psychosocial approaches, 
cognitive behavioural therapy (CBT) may potentially serve as a treatment option both for 
anxiety symptoms and also for the optimal seizure control (Ekinci et al., 2009; Goldstein 
et., al 2003; Spector et al., 1999; Engelberts et al., 2002). CBT has been found to be effective 
in adult patients with epilepsy who have agoraphobia and OCD (Newsom-Davis et  
al., 1998). A more recent study showed CBT as an acceptable and promising treatment 
option for the patients with epilepsy and comorbid anxiety symptoms (Macrodimitri  
et al., 2011). 
4.2 Medical treatment  
A limited number of studies have focused on the pharmacotherapy of anxiety disorders in 
epilepsy to date. The available research have revealed that the SSRI group antidepressants 
appear to be safe and effective treatment options (Scicutella & Ettinger, 2002; Schmitz, 2002; 
Kanner et al., 2000; Jobe & Browning, 2005). The possible psychiatric and/or therapeutic 
effects of AED also deserve attention. Some AED including valproate, gabapentin, tiagabine 
and vigabatrine have been reported to anxiolytic effects and have been used with varying 
success in the treatment of anxiety disorders in adult studies (Johannessen Landmark, 2008; 
Kinrys et al., 2003;  Blanco et al., 2003, Pande et al., 2000,2003; Rosenthal, 2003). Several 
hypotheses and suggestions have been made for why some AEDs have anti-anxiety effects 
(Ketter et al., 1999). There is some evidence that the past history and family history  of 
psychiatric disorders may increase the risk of psychiatric side effects with AEDs (Mula & 
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Monaco, 2007; Marsh & Rao, 2002). It is suggested that the AEDs that attenuate glutamate 
excitatory neurotransmission (e.g., lamotrigine) may cause neurotransmitter activation that 
leads to an increase in anxiety and GABAergic AEDs may serve to decrease anxiety  (e.g., 
barbiturates, benzodiazepines, valporate, tiagabine, gabapentin and vigabatrin) (Ketter et 
al., 1999; Mula & Monaco, 2007). Beyond this theoretical explanation, there are no placebo-
controlled studies on the anxiolytic effects of AEDs in adults or pediatric patients with 
epilepsy. Nevertheless, based on the extant literature thus far, it is reasonable to consider 
choosing an AED with anxiolytic potential in a patient with epilepsy who also has a 
comorbid anxiety disorder. (Scicutella & Ettinger,  2002; Beyenburg et al., 2005; Mula & 
Monaco 2007).   
5. The differential diagnosis of seizures and anxiety disorders 
It is important to note that this chapter mainly discusses the anxiety disorders in patients 
with epilepsy which are unrelated with seizure events. This type of anxiety is defined as 
interictal anxiety. However, patients with epilepsy can also experience increased levels  of 
anxiety at different stages of the seizure events, such as preictally, ictally, or postictally. Ictal 
anxiety  is defined as anxiety symptoms during the seizure event. Ictal anxiety is known to 
be associated with focal seizures of temporal origin, particularly when there is amygdalar 
involvement (Marsh & Rao 2002; Vasquez & Devinsky 2003). Anxiety as a postictal 
phenomenon refers to the anxiety symptoms shortly after a seizure or a cluster of seizures 
(Kanner et al., 2004).  This type of anxiety may be associated with dysphoria or depressive 
symptoms (Kanner & Palac, 2000). Postictal anxiety  symptoms similar to those in panic 
attacks can be observed in temporal lobe epilepsy and less frequently in extratemporal lobe 
epilepsies (Beyenburg et al., 2005). The differential diagnosis of seizure-related events is 
sometimes problematic for the clinicians since such events may  be misled by panic attacks 
that present like complex partial seizures (Bernik et al., 2002). Differentiating symptoms that 
are more suggestive of a seizure include motor automatisms, alterations in consciousness, 
the possible presence of an aura and postictal confusion (Vasquez & Devinsky 2003; 
Scicutella & Ettinger, 2002). In addition, panic attacks usually last several minutes whereas 
seizures are usually more brief. The exception to this, of course, is seizures that secondarily 
generalize or progress to status epilepticus (Ekinci et al., 2009). Complicated cases may 
warrant further investigation with EEG, Video EEG monitoring, and/or brain imaging 
studies (Handal et al., 1995). 
6. Suggestions and future research  
When compared with depression, less attention has been focused on anxiety disorders in 
epilepsy. The factors that have been suggested for the increased risk of anxiety disorders in 
epilepsy are reviewed in Figure 1. For the management of this disabling comorbidity, 
different strategies including psychosocial, behavioral and medicational interventions are 
found to be helpful. However, for an  effective management, gaining optimal seizure control 
must be the first step. Without total seizure control, complete treatment of anxiety 
symptoms is considered unlikely (Ekinci et al., 2009; Beyenburg et al., 2005). Further 
research is needed to better examine the specific phenomenology of anxiety disorders  
in patients with epilepsy in order to guide clinicians about when psychiatric referrals  
are needed. 
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Fig. 1. Overview of the factors associated with increased risk of anxiety disorders in patients 
with epilepsy 
Neurobiological factors: The role of of amygdala and GABA receptors 
Unpredictability of seizures, the fear of death, feeling of poor control over seizures and the 
perceived stigma 
Epilepsy related factors: Higher seizure frequency, focal epilepsy types (especially temporal 
lobe epilepsy) and epilepsy surgery (especially after temporal lobe surgery) 
Age of the patients:  In adults, later onset of epilepsy. In pediatric population, older age 
Role of antiepileptic drugs (AED): AED polytherapy and the effects of spesific AED on 
anxiety symptoms 
7. Conclusion 
Anxiety symptoms, either in the form of the DSM- IV diagnoses or single symptoms, are 
frequenty experienced in patients with epilepsy. Morever, anxiety in epilepsy is not simply a 
reactive emotional response to epilepsy or just a feature of the seizures. The current 
literature indicates that anxiety disorders are frequent comorbid conditions of epilepsy in 
children, adolescents and adults. The worries of the patients about having accidents, losing 
control and social embarrassment may be associated with an underdiagnosed or untreated 
anxiety disorder. Comprehensive and effective management of anxiety symptoms can be 
accomplished by a psychiatrist and/or psychologist, particularly when a the patients’ 
condition is more severe and/or refractory.  The collaboration between different disciplines, 
including the psychiatry and neurology specialists, offers the best hope for early 
identification and treatment of anxiety disorders in epilepsy. Because of the potentially 
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severe impact of anxiety disorders on the quality of life in patients with epilepsy, anxiety 
symptoms should be screened and treated early in this special population.  
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